News
The Supreme Court will address a petition regarding rare side effects linked to the Covishield vaccine, developed by AstraZeneca and Oxford University. The petition demands expert investigation and government compensation for affected families. AstraZeneca last month acknowledged the vaccine’s potential to cause thrombosis with thrombocytopenia syndrome (TTS), prompting global concerns.